GSK plc
Insider Reports History
- Location
- London
- Signature
- /s/ Victoria Whyte, Authorized Signatory, GSK plc
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by GSK plc:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd. | 10%+ Owner | Ordinary Shares | 18,245,691 | $346,668,129 | $19.00 | 11 Dec 2025 | By Corporation |
| Lyell Immunopharma, Inc. | 10%+ Owner | Common Stock | 30,253,189 | $68,977,271 | $2.28 | 21 Jun 2021 | Indirect |
| CVRx, Inc. | 10%+ Owner | Common Stock | 1,007,583 | $18,695,602 | $18.55 | 02 Jul 2021 | Indirect |
| Spero Therapeutics, Inc. | 10%+ Owner | Common Stock | 9,190,606 | $11,672,070 | $1.27 | 07 Nov 2022 | Indirect |
| CVRx, Inc. | 10%+ Owner | Series B-2 Preferred Stock | 0 | 02 Jul 2021 | Indirect | ||
| CVRx, Inc. | 10%+ Owner | Series C-2 Preferred Stock | 0 | 02 Jul 2021 | Indirect | ||
| CVRx, Inc. | 10%+ Owner | Series D-2 Preferred Stock | 0 | 02 Jul 2021 | Indirect | ||
| CVRx, Inc. | 10%+ Owner | Series E-2 Preferred Stock | 0 | 02 Jul 2021 | Indirect | ||
| CVRx, Inc. | 10%+ Owner | Series F-2 Preferred Stock | 0 | 02 Jul 2021 | Indirect | ||
| CVRx, Inc. | 10%+ Owner | Series G Preferred Stock | 0 | 02 Jul 2021 | Indirect | ||
| Innoviva, Inc. | 10%+ Owner | Common Stock | 0 | $16.05 | 20 May 2021 | Indirect | |
| Lyell Immunopharma, Inc. | 10%+ Owner | Series AA Preferred Stock | 0 | 21 Jun 2021 | Indirect | ||
| Theravance Biopharma, Inc. | Former 10% Owner | Ordinary Shares | 0 | $10.29 | 16 Sep 2022 | By Corporation | |
| Theravance Biopharma, Inc. | Former 10% Owner | Exchangeable Senior Notes due 2023 | 0 | 16 Sep 2022 | Indirect |
Insider Reports Filed by GSK plc
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | 11 Dec 2025 | 1 | +$27,930,000 | 4 | 10%+ Owner | 15 Dec 2025, 16:32 |
| WVE | Wave Life Sciences Ltd. | 27 Sep 2024 | 1 | +$22,335,440 | 4 | 10%+ Owner | 01 Oct 2024, 17:54 |
| WVE | Wave Life Sciences Ltd. | 07 Dec 2023 | 1 | +$16,500,000 | 4 | 10%+ Owner | 30 Jan 2024, 16:39 |
| WVE | Wave Life Sciences Ltd. | 23 Jan 2023 | 0 | $0 | 3 | 10%+ Owner | 30 Jan 2023, 15:34 |
| SPRO | Spero Therapeutics, Inc. | 07 Nov 2022 | 0 | $0 | 3 | 10%+ Owner | 14 Nov 2022, 16:05 |
| TBPH | Theravance Biopharma, Inc. | 16 Sep 2022 | 2 | +$175,024,132 | 4 | Former 10% Owner | 20 Sep 2022, 16:16 |
| CVRX | CVRx, Inc. | 02 Jul 2021 | 13 | +$4,950,000 | 4 | 10%+ Owner | 06 Jul 2021, 16:38 |
| CVRX | CVRx, Inc. | 29 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 06 Jul 2021, 16:22 |
| LYEL | Lyell Immunopharma, Inc. | 21 Jun 2021 | 2 | $0 | 4 | 10%+ Owner | 23 Jun 2021, 18:14 |
| MEHCQ | 23andMe Holding Co. | 16 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 04 Nov 2022, 16:11 |
| LYEL | Lyell Immunopharma, Inc. | 16 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 17 Jun 2021, 17:56 |
| INVA | Innoviva, Inc. | 20 May 2021 | 1 | -$392,064,435 | 4 | 10%+ Owner | 24 May 2021, 17:04 |